Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Thorax. 2004 May;59(5):428-33.

Prognostic significance of cyclooxygenase-2 (COX-2) and expression of cell cycle inhibitors p21 and p27 in human pleural malignant mesothelioma.

Author information

  • 1Department of Biochemistry and Biophysics, F Cedrangolo, Section of Anatomic Pathology, Second University of Naples, Naples, Italy.alfonsobaldi@tiscali.it

Erratum in

  • Thorax. 2004 Jun;59(6):543.

Abstract

BACKGROUND:

A study was undertaken to analyse the potential prognostic value of the immunohistochemical expression of cyclooxygenase-2 (COX-2) and p27 in 29 malignant mesotheliomas already screened for the expression of p21 and p53.

METHODS:

Immunohistochemistry was used to determine the expression of COX-2 and p27. The correlation with survival of these factors and of p21 and p53 expression was assessed by univariate and multivariate analyses.

RESULTS:

A positive statistically significant correlation was found between p27 and p21 expression (p<0.0001), but there was a negative correlation between COX-2 expression and both p27 (p = 0.001) and p21 (p<0.0001). No statistically significant correlation was recorded between p53 and all the other immunohistochemical parameters. Univariate analysis showed that overall survival was strongly influenced by p21, p27, and COX-2 expression, but multivariate Cox regression analysis showed that the only immunohistochemical parameter to influence overall survival of patients with mesothelioma was COX-2.

CONCLUSIONS:

These findings suggest that COX-2 expression may be a useful prognostic parameter for mesothelioma.

PMID:
15115874
[PubMed - indexed for MEDLINE]
PMCID:
PMC1746992
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Write to the Help Desk